San Francisco Brain Research Institute Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2003
NCT00211380
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

SAM Technology & The San Francisco Brain Research Institute

Active Ingredients

Drugs in Other Trials (1)

aripiprazole (abilify) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1